Retrospective Comparison of CD34-selected Allogeneic Peripheral Blood Stem Cell Transplantation Followed by CD8-depleted Donor Lymphocyte Infusions with Unmanipulated Bone Marrow Transplantation

References

• Ferrara, J.L., Levy, R. and Chao, N.J. (1999) "Pathophysiologic mechanisms of acute graft-versus-host disease", Biol. Blood Marrow Transplant. 5, 347–356.
   PubMedGoogle Scholar
• Goerner, M., Gooley, T., Flowers, ED., Sullivan, K.M., Kiem, H.P., Sanders, J., Martin, P.J. and Storb, R. (2002) "Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias", Biol. Blood Marrow Transplant. 8, 47–56.
   PubMed Web of Science ®Google Scholar
• Ferrara, J.L. (2000) "Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors", J. Hematother. Stem Cell Res. 9, 299–306.
   PubMedGoogle Scholar
• Drobyski, W.R. (2000) "Evolving strategies to address adverse transplant outcomes associated with T cell depletion", J. Hematother. Stein Cell Res. 9, 327–337.
   PubMedGoogle Scholar
• Ho, VT. and Soiffer, R.J. (2001) "The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation", Blood 98, 3192–3204.
   PubMed Web of Science ®Google Scholar
• Baron, F. and Beguin, Y. (2000) "Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation", Transfusion 40, 468–476.
   PubMed Web of Science ®Google Scholar
• Barrett, J. and Childs, R. (2000) "The benefits of an alloresponse: graft-versus-tumor", J. Hematother. Stem Cell Res. 9, 347–354.
   PubMedGoogle Scholar
• Slavin, S., Morecki, S., Weiss, L. and Or, R. (2002) "Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation", J. Hematother. Stein Cell Res. 11, 265–276.
   PubMedGoogle Scholar
• Naparstek, E., Or, R., Nagler, A., Cividalli, G., Engelhard, D., Aker, M., GimonMarmy, N., Sacks, T. and Tochner, Z. (1995) "T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse", Br. J. Haematol. 89, 506–515.
   PubMed Web of Science ®Google Scholar
• Barrett, A.J., Mavroudis, D., Tisdale, J. and Read, E. (1998) "T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect", Bone Marrow Transplant. 21, 543–551.
   PubMed Web of Science ®Google Scholar
• Lee, C.K., Gingrich, R.D., de Magalhaes-Silverman, M., Hohl, R.J., Joyce, J.K., Scott, S.D., Wen, B.C. and Schlueter, A. (1999) "Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation", Biol. Blood Marrow Transplant. 5, 15–27.
   PubMedGoogle Scholar
• Martino, R., Martin-Henao, G., Sureda, A., Altes, A., Canals, C., Brunet, S. and Sierra, J. (2000) "Allogeneic peripheral blood stem cell transplantation with CD34-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study", Haematologica 85, 1165–1171.
   PubMed Web of Science ®Google Scholar
• Alyea, E.P., Weller, E., Schlossman, R., Canning, C., Webb, I., Doss, D., Mauch, P., Marcus, K., Fisher, D., Freeman, A., Parikh, B., Gribben, J.G. and Soiffer, R.J. (2001) "T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect", Blood 98, 934–939.
   PubMed Web of Science ®Google Scholar
• Schaap, N., Schattenberg, A., Bar, B., Preijers, F., van de Wiel, van Kemenade and De Witte, T. (2001) "Induction of graft-versus-leukemia to prevent relapse after partially lympho-cyte-depleted allogeneic bone marrow transplantation by pre- emptive donor leukocyte infusions", Leukemia 15, 1339–1346.
   PubMed Web of Science ®Google Scholar
• Nakamura, R., Bahceci, E., Read, E.J., Leitman, S.F., Carter, C.S., Childs, R., Dunbar, C.E., Gress, R., Altemus, R., Young, N.S. and Barrett, A.J. (2001) "Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back", Br. J. Haematol. 115, 95–104.
   PubMed Web of Science ®Google Scholar
• Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.P., Fillet, G. and Beguin, Y. (2002) "Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell trans-plantation", Haematologica 87, 78–88.
   PubMed Web of Science ®Google Scholar
• Giralt, S., Hester, J., Huh, Y. and Champlin, R. (1995) "CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation", Blood 86, 4337–4343.
   PubMed Web of Science ®Google Scholar
• Alyea, E.P., Soiffer, R.J., Canning, C. and Ritz, J. (1998) "Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant", Blood 91, 3671–3680.
   PubMed Web of Science ®Google Scholar
• Shimoni, A., Gajewski, J.A., Donato, M., Martin, T., O'Brien, S., Talpaz, M., Cohen, A., Korbling, M., Champlin, R. and Giralt, S. (2001) "Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation", Biol. Blood Marrow Trans-plant. 7, 568–575.
   PubMed Web of Science ®Google Scholar
• Przepiorka, D., Weisdorf, D., Martin, E, Klingemarm, H.G., Beatty, P., Hows, J. and Thomas, E.D. (1995) "1994 Consensus Conference on acute GVHD grading", Bone Marrow Trans-plant. 15, 825–828.
   PubMed Web of Science ®Google Scholar
• Margolis, J. and Vogelsang, G. (2000) "Chronic graft-versus-host disease", J. Hematother. Stem Cell Res. 9, 339–346.
   PubMedGoogle Scholar
• Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G. and Beguin, Y. (2002) "Nonmyeloablative stem cell transplan-tation (NMSCT) with CD8-depleted or CD34-selected PBSC", J. Hematother Stem Cell Res. 11, 301–314.
   PubMedGoogle Scholar
• Champlin, R., Schmitz, N., Horowitz, M.M., Chapuis, B., Gale, R.P., Goldman, J.M., Montserrat, E. and Ringden, O. (2000) "Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation", Blood 95, 3702–3709.
   PubMed Web of Science ®Google Scholar
• Blaise, D., Attal, M., Reiffers, J., Michallet, M., Bellanger, C., Pico, J.L., Stoppa, A.M., Payen, C., Marit, G., Bouabdallah, R. and Sotto, J.J. (2000) "Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission", Fur. Cytokine Netw. 11, 91–98.
   PubMed Web of Science ®Google Scholar
• Bensinger, WI., Martin, P., Clift, R.A., Storer, B., Forman, S., Clift, R.A., Kashyap, A., Negrin, R.S., Libelly, K., Chauncey, T.R., Storb, R. and Appelbaum, ER. (2001) "Transplantation of bone marrow as compared with peripheral blood stem cells from HLA identical relatives in patients with hematologic cancers", N. Engl. J. Med. 344, 175–181.
   PubMed Web of Science ®Google Scholar
• Martinez, C., Urbano-Ispizua, A., Rozman, C., Mann, P., Rovira, M., Sierra, J., Montfort, N., Carreras, E. and Montserrat, E. (1999) "Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34 + selected grafts with recipients of unmanipulated grafts", Exp. Hematol. 27, 561–568.
   PubMed Web of Science ®Google Scholar
• Baron, F. and Beguin, Y. (2002) "Pre-emptive cellular therapy after T-cell depleted allogeneic stem cell transplantation", Biol. Blood Marrow Transplant., In press.
   Google Scholar
• Powles, R., Mehta, J., Kulkarni, S., Treleaven, J., Millar, B., Marsden, J. and Singhal, S. (2000) "Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial", Lancet 355, 1231–1237.
   PubMed Web of Science ®Google Scholar
• Klingemann, H.G. (2001) "Cellular therapy of cancer with natural killer cells: will it ever work?", J. Hematother. Stem Cell Res. 10, 23–26.
   PubMedGoogle Scholar
• Alyea, E.P. (2000) "Adoptive immunotherapy: insights from donor lymphocyte infusions", Transfusion 40, 393–395.
   PubMed Web of Science ®Google Scholar
• Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C. and Speck, B. (1990) "Graft-versus-leukemia reactions after bone marrow transplantation", Blood 75, 555–562.
   PubMed Web of Science ®Google Scholar
• Appelbaum, F.R. (1997) "Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)", Leukemia 11\(Suppl. 4), S15—S17.
   PubMedGoogle Scholar